Relationship between oxidative stress, ferritin and insulin resistance in sickle cell disease

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 6, 2010, Pages 527-538

  Alsultan, A I ^a   Seif, Mosaad Ahmad ^a   Amin, T T ^a   Naboli, M ^a   Alsuliman, A M ^a  

^a KING FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Ferritin; Insulin resistance; Sickle cell

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; FERRITIN; GLUTATHIONE PEROXIDASE; INSULIN; MALONALDEHYDE; MEMBRANE LIPID; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HUMAN CELL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; IRON OVERLOAD; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; SICKLE CELL ANEMIA; SPECTROPHOTOMETRY; BLOOD; METABOLISM;

ADULT; ANEMIA, SICKLE CELL; FEMALE; FERRITINS; HUMANS; INSULIN RESISTANCE; MALE; OXIDATIVE STRESS;

EID: 77955819260     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. WANG WC. Sickle cell anemia and other sickling syndromes. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B. (eds). Wintrobe's clinical hematology. 11th ed. Philadelphia: Lippincott Williams and Wilkins; 2004: pp. 1264-1311.
2. AGARWAL MB. The burden of haemoglobinopathies in India-time to wake up? J Assoc Physicians India 2005; 53: 1017-18.
3. AL-ALI AK. Pyridine nucleotide redox potential in erythrocytes of saudi subjects with sickle cell disease. Acta Haematol 2002; 108: 19-22
4. STOCKS J, OFFERMAN EL, MODELL CB, DORMANDY TL. The susceptibility to autoxidation of human red cell lipids in health and disease. Br J Haematol 1972; 23: 713-724.
5. WINTERBOURN CC. Oxidative denaturation in congenital hemolytic anemias: The unstable hemoglobins. Semin Hematol 1990; 27: 41-50.
6. LACHANT NA, TANAKA KR. Antioxidants in sickle cell disease: The in vitro effects of ascorbic acid. Am J Med Sci 1986; 292: 3-10. (Pubitemid 17057420)
7. ZIMMERMANN CP, NATTA C. Glutathione peroxidase activity in whole blood of patients with sickle cell anemia. Scand J Haematol 1981; 26: 177-181.
8. SCHACTER L, WARTH JA, GORDON EM, PRASAD A, KLEIN BL: Altered amount and activity of superoxide dismutase in sickle cell anemia. FASEB J 1988; 2: 237-243.
9. BERETTA L, GERLI GC, FERRARESI R, AGOSTONI A, GUALANDRI V, ORSINI GB. Antioxidant system in sickle red cells. Acta Haematol 1983; 70: 194-197.
10. DAS SK, NAIR RC. Superoxide dismutase, glutathione peroxidase, catalase and lipid peroxidation of normal and sickled erythrocytes. Br J Haematol 1980; 44: 87-92.
11. TITUS J, CHARI S, GUPTA M, PAREKH N. Pro-oxidant and anti-oxidant status in patients of sickle cell anemia. Indian J Clin Biochem 2004; 19: 168-172.
12. MANFREDINI V, LAZZARETTI LL, GRIEBELER IH, SANTIN AP, BRANDÃO VDM, WAGNER S, CASTRO SM, PERALBA MD-CR, BENFATO MS. Blood Antioxidant Parameters in Sickle Cell Anemia Patients in Steady State. J National Med Assoc 2008; 100: 897-902.
13. FASOLA F, ADEDAPO K, ANETOR J, KUTI M. Total antioxidants status and some hematological values in sickle cell disease patients in steady state. J National Med Assoc 2007; 99: 891-894.
14. JAIN SK, SHOHET SB. A novel phospholipid in irreversibly sickled cells: evidence for in vivo peroxidative membrane damage in sickle cell disease. Blood. 1984; 63: 362-367.
15. ESSIEN EU. Increased susceptibility of erythrocyte membrane lipids to peroxidation in sickle cell disease. Central African J Med 1994; 40: 217-220.
16. TRUGLIA JA, LIVINGSTON JN, LOCKWOOD DH. Insulin resistance: receptor and post-binding defects in human obesity and non-insulin-dependent diabetes mellitus. Am J Med 1985; 979(Suppl. 2B): 13-21.
17. BERTELSEN M, ANGGARD EE, CARRIER MJ. Oxidative stress impairs insulin internalization in endothelial cells in vitro. Diabetologia 2001; 44: 605-613. (Pubitemid 32411277)
18. ANDO K, FUJITA T. Metabolic syndrome and oxidative Stress. Free Radic Biol Med 2009; 47: 213-218.
19. MATTHEWS DR, HOSKER JP, RUDENSKI AS, NAYLOR BA, TREACHER DF, TURNER RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985; 28: 412-429.
20. JEHN M, CLARK JM, GUALLAR E. Serum ferritin and risk of the metabolic syndrome in U.S. adults. Diabetes Care 2004; 27: 2422-2428.
21. FERNANDEZ-REAL JM, RICART-ENGEL W, ARROYO E, BALANCA R, CASAMITJANA-ABELLA R, CABRERO D, FERNANDEZ-CASTANER M, SOLER, J. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 1998; 21: 62-68.
22. SUN L, FRANCO OH, HU FB, CAI L, YU Z, LI H, YE X, QI Q, WANG J, PAN A, LIU Y, LIN X. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocr Metab 2008; 93: 4690-4696.
23. BRITTENHAM GM, COHEN AR, MCLAREN CE, MARTIN MB, GRIFFITH PM, NIENHUIS AW, YOUNG NS, ALLEN CJ, FARRELL DE, HARRIS JW. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol 1993; 42: 81-85.
24. EL-NAGGAR MM. Protective action of some Cu II complexes against photohemolysis induced by m-chloroperbenzoic acid. J Inorg Biochem 1997; 65: 263-266.
25. BAURE JD. Laboratory investigation of hemoglobin. In: Gradwohl's Clinical Laboratory Methods and Diagnosis, edited by Sonnenwirth AC, Jarett L. St. Louis, MO: Mosby, 1980, pp. 809-902.
26. MARKS V. An improved glucose-oxidase method for determining blood, CSF, and urine glucose levels. Clin Chim Acta 1996; 251: 19-24.
27. LEVINE RL GARLAND D, OLIVER CN, AMIRI A, CLIMENT I, LENZ AG, AHN BW, SHALTIEL S, STADTMAN ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186; 464-478.
28. AEBI HE. Catalase of enzymatic analysis. In: Methods in Enzymology. Enzymes 1: Oxidoreductases, Transferases, edited by Bergmeyer HU. Weinheim, Germany: VCH Verlagsgesell Schaft, 1987, vol. III, pp. 273-285.
29. HALLIWELL B, GUTTERIDGE JMC. Cellular responses to oxidative stress: adaptation, damage, repair, senescence and death. In: Halliwell B, Gutteridge JMC, eds. Free Radicals in Biology and Medicine, 3rd ed. New York: Oxford University Press; 2007: pp. 187-267.
30. PAGLIA DE VALANTINE WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
31. ANDERSEN L, DINESEN B, JORGENSEN PN, POULSEN F, RODER ME. Enzyme immunoassay for intact human insulin in serum or plasma Clin Chem 1993; 39: 578-582.
32. HUSSAIN MA, DAVIS LR, LAULICHT M, HOFFBRAND AV. Value of serum ferritin estimation in sickle cell anaemia. Arch Dis Child 1978; 53: 319-321
33. ASLAN M, THORNLEY-BROWN D, FREEMAN BA. Reactive oxygen species in sickle cell disease. Ann NY Acad Sci. 2000; 899: 375-391. (Pubitemid 30352801)
34. WOOD KC, GRANGER DN. Sickle cell disease: Role of reactive oxygen and nitrogen metabolites. Clin Exper Pharm Physiol 2007; 34: 926-932. (Pubitemid 47083959)
35. JAIN SK, ROSS JD, LEVY GJ, DUETT J. The effect of malonyldialdehyde on viscosity of normal and sickle red blood cells. Biochem Med Metab Biol 1990; 44: 37-41. (Pubitemid 20277300)
36. WOOD KC, HSU LL GLADWIN MT. Sickle cell disease vasculopathy: A state of nitric oxide resistance. Free Radic Biol Med 2008; 44: 1506-1528.
37. DINCER Y, AKCAY T, ALADEMIR Z, ILKOVA H. Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002; 51: 1360-1362.
38. MACHLIN LJ, BENDICH A. Free radical tissue damage: Protective role of antioxidant nutrients. FASEB J 1987; 1: 441-445.
39. LIU X, HINTZE K, LONNERDAL B, THEIL EC. Iron at the center of ferritin, metal/oxygen homeostasis and novel dietary strategies. Biol Res 2006; 39: 167-171.
40. BROWN K, SUBRAMONY C, MAY W, MEGASON G, LIU H, BISHOP P, WALKER T, NOWICKI MJ. Hepatic iron overload in children with sickle cell anemia in chronic transfusion therapy. J Pediat Hematol/Oncol 2009; 31: 309-312.
41. GORDEUK VR, REBOUSSIN DM, MCLAREN CE, BARTON JC. Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population. Am J Hematol 2008; 83: 618-626.
42. YOKOMORI N, IWASA Y, ADA K, INOUE M, TAWATA M, ONAYA T. Transcriptional regulation of ferritin messenger ribonucleic acid levels by insulin in cultured rat glioma cells. Endocrinology 1991; 128: 1474-1480.
43. CAIRO G, TACCHINI L, POGLIAGHI G, ANZON E, TOMASI A, BERNELLI-ZAZZERA A. Induction of ferritin synthesis by oxidative stress. Transcriptional and posttranscriptional regulation by expansion of the "free" iron pool. J Biol Chem 1995; 270: 700-703.
44. CHAKRABORTY C. Biochemical and molecular basis of insulin resistance. Curr Protein Peptide Sci 2006; 7: 113-131.
45. HOUSTIS N, ROSEN ED, LANDER ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
46. DOKKEN BB, SAENGSIRISUWAN V, KIM JS, TEACHEY MK, HENRIKSEN EJ. Oxidative stress-induced insulin resistance in rat skeletal muscle: role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab 2008; 294: E615-E621.
47. GARVEY WT, MAIANU L, ZHU J-H, BRECHTEL-HOOK G, WALLACE P, BARON AD. Evidence for defects in the trafficking and translocation of GLUT 4 glucose transporters in skeletal muscle as a cause of human insulin resistance. J Clin Invest 1998; 101: 2377-2386.
48. SINGH I, CAREY AL, WATSON N, FEBBRAIO MA, HAWLEY JA. Oxidative stress-induced insulin resistance in skeletal muscle cells is ameliorated by gamma-tocopherol treatment. Eur J Nutr 2008; 47: 387-392.
49. LORENZO C, WAGENKNECHT LE, D'AGOSTINO RB JR., REWERS MJ, KARTER AJ, HAFFNER SM. Insulin resistance, {beta}-cell dysfunction, and conversion to Type 2 Diabetes in a multiethnic population: the Insulin resistance atherosclerosis study. Diabetes Care 2010; 33: 67-72
50. NIEDERAU C, BERGER M, STREMMEL W, STARKE A, STROHMEYER G, EBERT R, SIEGEL E, CREUTZFELDT W: Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 1984; 26: 441-444.
51. CHIU KC, CHUANG LM, YOON C, SAAD MF. Hepatic glucokinase promoter polymorphism is associated with hepatic insulin resistance in Asian Indians. BMC Genetics 2000; 1: 1-6.
52. FACCHINI FS. Effect of phlebotomy on plasma glucose and insulin concentrations. Diabetes Care 1998; 21: 2190-2194.
53. DONGIOVANNI P, VALENTI L, FRACANZANIAL, GATTI S, CAIRO G, FARGION S. Iron depletion by Desferoxamine up-regulates glucose uptake and insulin signaling in hepatoma cells and in rat liver. Am J Pathol 2008;172:738-747
54. HUA NW, STOOHS RA, FACCHINI FS. Low iron status and enhanced insulin sensitivity in lacto-ovo vegeterians. Br J Nutr 2001; 86: 515-519.